ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Greenpeace Report Says Chemicals Causing Breast Cancers

October 22, 1993

Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.

November 14, 2003

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

More DCT Concepts Approved By Advisors

July 10, 1992

ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program

April 13, 1979

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980